USANA Health Sciences, Inc.USNA

$18.88+0.48 (+2.61%)
NYSEConsumer Defensive24:00 UTC

Company snapshot

Market Cap
$348M
Small-cap
-76%
2016 — today
10-Year Price
-68%
2016 — today
52-Week Range
$16.90$35.43
Current $18.88· 11%

USANA Health Sciences, Inc. specializes in the development, manufacturing, and direct sale of science-based nutritional supplements and personal care products. Its diverse product portfolio includes foundational nutrition, such as the Essentials/CellSentials vitamin and mineral supplements designed to support overall health across various age demographics. Complementing these are targeted optimizers addressing specific needs like cardiovascular, skeletal, or digestive well-being, alongside a range of food items including meal replacement shakes and snack bars. The company's personal care line, Celavive, provides a comprehensive skincare regimen suitable for diverse skin types and ethnic backgrounds. Additionally, USANA offers specialized products catering to prenatal, infant, and young child age groups. To empower its independent associates, USANA provides extensive materials and online resources to facilitate business development and product marketing. Its products are distributed directly to consumers and online across key markets in the Asia Pacific region, the Americas, and Europe. Furthermore, USANA maintains research collaboration agreements with institutions like the Beijing University of Chinese Medicine for traditional Chinese medicine studies and the National Sports Training Bureau. Established in 1992, USANA Health Sciences, Inc. is headquartered in Salt Lake City, Utah.

Valuation in context

P/E ratio
39.9
Near historic high
Near historic highs — last 10 years
P/B ratio
0.6
Near historic low
Near historic low — last 10 years
EV / EBITDA
2.5
Near historic low
Near historic low — last 10 years
FCF Yield
0.9%
Near historic low
Near historic low — last 10 years
Free · No credit card needed

Get alerted when USNA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.